Skip to main content
SpringerLink
Log in

Erosive osteoarthritis: Presentation, clinical pearls, and therapy

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Erosive osteoarthritis (OA) is a subcategory of OA in which destructive changes occur in the joints, probably as a result of a combination of inflammatory inciters and phenomena. The major changes occur in the distal and proximal interphalangeal joints, root joints of the thumb, and less commonly other hand and centripetal joints. A familial tendency suggests hereditary predisposition, and women more likely to be afflicted than men. Diagnosis has been enhanced by newer imaging techniques such as sonography and scintigraphy. Treatment remains chiefly palliative, although there are hints that alleviation of inflammation may be more salutary than simple analgesia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Sharma L: Epidemiology of osteoarthritis. In Osteoarthritis, edn 3. Edited by Moskowitz RW, et al. Philadelphia, PA: WB Saunders; 2001:3.

    Google Scholar 

  2. Hadler NM: Knee pain is the malady: not osteoarthritis. Ann Intern Med 1992, 116:598–599. While an older paper, this editorial offers a philosophy that separates symptoms and signs, avoiding a confusion of what treatment of osteoarthritis really implies.

    PubMed  CAS  Google Scholar 

  3. Ehrlich GE: Inflammatory osteoarthritis, I: The clinical syndrome. J Chronic Dis 1972, 25:317–328.

    Article  PubMed  CAS  Google Scholar 

  4. Ehrlich GE: Osteoarthritis beginning with inflammation. Definitions and correlations. JAMA 1975, 232:157–159.

    Article  PubMed  CAS  Google Scholar 

  5. Crain DC: Interphalangeal osteoarthritis characterized by painful, inflammatory episodes, resulting in deformity of the proximal and distal articulations. JAMA 1961, 175:1949–1953.

    Google Scholar 

  6. Cicuttini FM, Baker J, Hart DJ, et al.: Relation between Heberden’s nodes and distal interphalangeal osteophytes and their role as markers of generalized disease. Ann Rheum Dis 1998, 57:246–248.

    Article  PubMed  CAS  Google Scholar 

  7. Stecher RM: Heberden’s nodes. A clinical description of osteoarthritis in the finger joint. Ann Rheum Dis 1955, 14:1–10.

    Article  PubMed  CAS  Google Scholar 

  8. Kidd KL, Peter JB: Erosive osteoarthritis. Radiology 1966, 86:640–647.

    PubMed  CAS  Google Scholar 

  9. Peter JB, Pearson CM, Marmor L: Erosive osteoarthritis of the hands. Arthritis Rheum 1966, 9:365–388.

    Article  PubMed  CAS  Google Scholar 

  10. Verbruggen G, Veys EM: Erosive and non-erosive hand osteoarthritis. Use and limitation of systems. Osteoarthritis Cartilage 2000, 8:S45–54. Although the major erosive changes occur in hand, and to a lesser extent, feet joints, similar changes rarely develop in major joints. For example, this article includes a description of four patients with sawtooth patello-femoral arthritis.

    Article  PubMed  Google Scholar 

  11. Wright GD, Regan M, Deighton CM, et al.: Evidence for genetic anticipation in nodal osteoarthritis. Ann Rheum Dis 1998, 57:524–526.

    PubMed  CAS  Google Scholar 

  12. Guenther KP, Stuermer T, Sauerland S, et al.: Prevalence of generalized osteoarthritis in patients with advanced hip and knee osteoarthritis. The Ulm osteoarthritis study. Ann Rheum Dis 1998, 57:717–723.

    Google Scholar 

  13. Segal R, Avrahami E, Lebdinski E, et al.: The impact of hemiparalysis on the expression of osteoarthritis. Arthritis Rheum 1998, 41:2249–2256.

    Article  PubMed  CAS  Google Scholar 

  14. Balbosa B, Cirillo R, Malara B: La rizartrosi del police. Rheumatilismo 1968, 20:195–208.

    Google Scholar 

  15. Chandnani V, Resnick D: Radiologic diagnosis. In Osteoarthritis, edn 3. Edited by Moskowitz RW, Howell DS, Altman RD, et al. Philadelphia: WB Saunders; 2001:253.

    Google Scholar 

  16. Ehrlich GE: Inflammatory osteoarthritis, II: The superimposition of rheumatoid arthritis. J Chronic Dis 1972, 25:635–643.

    Article  PubMed  CAS  Google Scholar 

  17. Olejarova M, Kupka K, Pavelka K, et al.: Comparison of clinical, laboratory, radiographic, and scintigraphic findings in erosive and nonerosive hand osteoarthritis. Results of a two-year study. Joint Bone Spine 2000, 67:107–112. An exegesis of the concepts that also offers a way to follow the progression of joint changes in OA, including that of erosive OA.

    PubMed  CAS  Google Scholar 

  18. Grassi W, Filipucci E, Farina A, et al.: Ultrasonography in the evaluation of bone erosions. Ann Rheum Dis 2001, 60:98–103. Objective follow-up of erosions in OA is now possible.

    Article  PubMed  CAS  Google Scholar 

  19. Walsh DA, Pearson CI: Angiogenesis in the pathogenesis of inflammatory joint and lung diseases. Arthritis Res 2001, 3:147–153. Inflammation causes and results from this vascular phenomenon.

    Article  PubMed  CAS  Google Scholar 

  20. Chikanza I, Fernandes L: Novel strategies for the treatment of osteoarthritis. Expert Opin Invest Drugs 2000, 9:1499–1510.

    Article  CAS  Google Scholar 

  21. Goldring MB: The role of the chondrocyte in osteoarthritis. Arthritis Rheum 2000, 43:1916–1926. Putting the blame where it belongs.

    Article  PubMed  CAS  Google Scholar 

  22. Yuan G-H, Masuko-Hongo K, Sakata M, et al.: The role of C-C chemokines and their receptors in osteoarthritis. Arthritis Rheum 2001, 44:1056–1070.

    Article  PubMed  CAS  Google Scholar 

  23. Goldring MB: The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res 1999, 40:1–11.

    PubMed  CAS  Google Scholar 

  24. Keyszer G, Lambiri I, Nagel R, et al.: Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/ TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. J Rheumatol 1999, 26:251–258.

    PubMed  CAS  Google Scholar 

  25. Bradley JD, Brandt KD, Katz BP, et al.: Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991, 325:87–91.

    Article  PubMed  CAS  Google Scholar 

  26. Brandt KD, Bradley JD: Should the initial drug to treat osteoarthritis pain be a nonsteroidal anti-inflammatory drug? J Rheumatol 2001, 28:467–473.

    PubMed  CAS  Google Scholar 

  27. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines: Recommendations for the medical management of osteoarthritis of the hip and knee. 2000 update. Arthritis Rheum 2000, 43:1905–1915. The controversy over appropriate treatment, analgesia versus antiinflammatory therapy, heats up. Reference 25 has been cited in recent years as justifying analgesic treatment but now, as the succeeding references document, the pendulum begins to swing more toward inflammation control. In erosive OA that may be more logical because long-term treatment is more likely than in the abatement of short bursts of pain in most OA.

    Article  Google Scholar 

  28. Wolfe F, Zhao S, Lane N: Preference for nonsteroidal anti-inflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum 2000, 43:378–385.

    Article  PubMed  CAS  Google Scholar 

  29. Felson DT: Editorial: The verdict favors nonsteroidal antiinflammatory drugs for treatment of osteoarthritis and a plea for more evidence on other treatments. Arthritis Rheum 2001, 44:1477–1480.

    Article  PubMed  CAS  Google Scholar 

  30. Pincus T, Koch GG, Sokka T, et al.: A randomized, doubleblind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip and knee. Arthritis Rheum 2001, 44:1587–1598.

    Article  PubMed  CAS  Google Scholar 

  31. Scott-Lennox JA, McLaughlin-Miley C, Lennox RD, et al.:Stratification of flare intensity identifies placebo responders in a treatment efficacy trial of patients with osteoarthritis. Arthritis Rheum 2001, 44:1599–1607.

    Article  PubMed  CAS  Google Scholar 

  32. Ashraf E, Cooper S, Kellstein D, et al.: Safety profile of nonprescription ibuprofen in the elderly osteoarthritis patient: a meta-analysis. Inflammopharmacology 2001, 9:35–42.

    Article  CAS  Google Scholar 

  33. Volans G: Current issues on the safety of non-prescription NSAIDs. Inflammopharmacology 2001, 9:43–50.

    Article  CAS  Google Scholar 

  34. Gilroy DW, Lawrence T, Colville-Nash P, et al.: New insights into inflammatory resolution. Inflammopharmacology 2001, 9:125–130.

    Article  CAS  Google Scholar 

  35. Jones RA: Etodolac (Lodine): Profile of an established COX-2 inhibitor. Inflammopharmacology 2001, 9:63–70.

    Article  CAS  Google Scholar 

  36. Degner F, Richardson B: Review of gastrointestinal tolerability and safety of Meloxicam. Inflammopharmacology 2001, 9:71–80.

    Article  CAS  Google Scholar 

  37. Simon LS: COX-2 inhibition: an advance or only pharmaceutical "hype"? Arthritis Care Res 2001, 45:209–215.

    Article  CAS  Google Scholar 

  38. Goldstein J: The clinical developments and future of the COX-2 inhibitor drugs. Inflammopharmacology 2001, 9:91–100.

    Article  CAS  Google Scholar 

  39. Pelletier J-P, Martel-Pelletier J, Abramson SB: Review: Osteoarthritis, an inflammatory disease: Potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001, 44:1237–1247.

    Article  PubMed  CAS  Google Scholar 

  40. Mandell BF: COX 2-selective NSAIDs: biology, promises, and concerns. Cleve Clin J Med 1999, 66:285–292.

    PubMed  CAS  Google Scholar 

  41. Hillson JL, Furst DE: Rofecoxib. Expert Opin Pharmacother 2000, 1:1053–1066.

    Article  PubMed  CAS  Google Scholar 

  42. Clemett D, Goa KL: Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain. Drugs 2000, 59:957–980.

    Article  PubMed  CAS  Google Scholar 

  43. Ramsey SD, Spencer AC, Topolski TD, et al.: Use of alternative therapies by older adults with osteoarthritis. Arthritis Care Res 2001, 45:228–227.

    Article  Google Scholar 

  44. Thie NMR, Prasad NG, Major PW: Evaluation of glucosamine sulfate compared to ibuprofen for the treatment of temporomandibular joint osteoarthritis: a randomized double blind controlled 3 month trial. J Rheumatol 2001, 28:1347–1355.

    PubMed  CAS  Google Scholar 

  45. Noyszewski EA, Wroblewski K, Dodge GR, et al.: Preferential incorporation of glucosamine into the galactosamine moieties of chondroitin sulfates in articular cartilage explants. Arthritis Rheum 2001, 44:1089–1095.

    Article  PubMed  CAS  Google Scholar 

  46. Mishra LC, Singh BB, Dagenais S: Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev 2000, 5:334–346.

    PubMed  CAS  Google Scholar 

  47. Long I, Soeken K, Ernst E: Herbal medicines for the treatment of osteoarthritis: A systematic review. Rheumatology 2001, 40:779–793.

    Article  PubMed  CAS  Google Scholar 

  48. Halbert J, Crotty M, Weller D, et al.: Primary care-based physical activity programs: effectiveness in sedentary older patients with osteoarthritis symptoms. Arthritis Care Res 2001, 45:228–234.

    Article  CAS  Google Scholar 

  49. Ehrlich GE, DiPiero AM: Stretch gloves: nocturnal use to ameliorate morning stiffness in arthritic hands. Arch Phys Med Rehabil 1971, 52:479–480.

    PubMed  CAS  Google Scholar 

  50. Bellamy N, Carr A, Dougados M, et al.: Towards a definition of "difference" in osteoarthritis. J Rheumatol 2001, 28:427–430.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Pennsylvania School of Medicine, One Independence Place #1101, 241 South Sixth Street, 19106-3731, Philadelphia, PA, USA

    George E. Ehrlich MD, MACR

Authors
  1. George E. Ehrlich MD, MACR
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ehrlich, G.E. Erosive osteoarthritis: Presentation, clinical pearls, and therapy. Curr Rheumatol Rep 3, 484–488 (2001). https://doi.org/10.1007/s11926-001-0062-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-001-0062-x

Keywords

Search

Navigation